GovChime
Notice ID: 617f30694f6c44509350dbb78c7a3a2fSolicitationArchived

MAXXEUS ALLOGRAFT HUMAN PRODUCT

Archived on October 2, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
11:00 AM CDT
Posted
September 15, 2025
Notice type
Solicitation
Set-aside
No Set aside used
Agency
Department of WarDepartment of the Army

Notice details

Office
US ARMY MEDICAL COMMAND.W40M MRC0 WEST
Place of performance
Texas, 78154
Last updated
Nov 8, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
W81K0025QA147
Notice ID
617f30694f6c44509350dbb78c7a3a2f

Description

FDA approved, AATB and TJC compliant Maxxeus Allograft Human Product

 Maxxues Allograft Costal Cartilage (2) <= 0.8 cm 4936-25             

QTY 12 each

Maxxues Allograft   Costal Cartilage (2) <= 0.8 cm 4935-25

QTY 12 each

Maxxues Allograft  Costal  Cartilage (2) <= 0.8 cm 4929-25

QTY 12 each

Maxxues Allograft  Costal Cartilage (2) <= 0.8 cm 4938-25

QTY 12 each

Salient Characteristics:


- Must be Food and Drug Administration (FDA), American Association of Tissue Banks (AATB), and regulated by The Joint Commission (TJC) compliant.
- Must be able to meet standards set forth by the FDA, AATB and TJC and conform to the rules and regulations set forth by the Army Medical Command.
- Must be able to provide a myriad of different tissues, allografts, and supplies associated with surgery.
- May provide safe biologic, metal, and synthetic implants.
- Must provide clinical solutions to wound management, reconstructive surgery, abdominal, and incisional management, but not limited to the items previous cited in the memorandum.
- Must have expediated delivery. Must be able to deliver within 24 hours of receiving an order.

The Government will award a Firm-Fixed-Price (FFP) contract resulting from this solicitation to the responsible offeror whose offer  conforming to the solicitation is the best value to the Government and provides fair and reasonable price. The quote shall conform  to the solicitation and be advantageous to the Government. Award will be made using the Lowest Price Technically Acceptable  (LPTA) process.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (2)

  • Solicitation - W81K0025QA147.pdf

    2.7 MBAdded in Solicitation version 3Posted
    Download
  • Solicitation Amendment W81K0025QA1470001 SF 30.pdf

    3.1 MBAdded in Solicitation version 3Posted
    Download

Lifecycle

  1. 1
    Version 1SolicitationArchived

    Allograft Human Skin Tissue

    Notice f7c39c1e9ac3471089e90eaa84668363 on SAM.gov

  2. 3
    Version 3SolicitationArchivedCurrent

    MAXXEUS ALLOGRAFT HUMAN PRODUCT

    Notice 617f30694f6c44509350dbb78c7a3a2f on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81K0025QA147

Archive Date

Oct 2, 2025

Office Address

JBSA FT SAM HOUSTON, TX, 78234-4504